Enovis is formerly Colfax Corporation and one of the world's leading orthopedic suppliers.
Enovis is a medical technology company focused on musculoskeletal health — formed through the 2022 transformation of Colfax Corporation and the 2023 acquisition of LimaCorporate. The company's Reconstructive segment, which includes the DJO and Lima brands, provides hip and knee reconstruction implants alongside a significant orthopedic bracing and recovery portfolio. Enovis is executing a focused strategy of building orthopedic reconstruction scale through organic growth and bolt-on acquisitions while leveraging its established position in functional bracing and rehabilitation devices.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Acquisitions and divestitures
• Marketing tactics
• Financial results
• Strengths and weaknesses
• Strategic directions
Table of Contents
1. Executive Summary
2. Company Overview and Business Model
3. Strategic Directions
4. Financial Results
5. SWOT Analysis
6. Technological Know-How and Key Products
7. Acquisitions and Divestitures
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Enovis — Key Financial Metrics 2023-2025
Table 2. Enovis — Revenue by Segment 2023-2025
Table 3. Enovis — Revenue by Geography 2023-2025
Table 4. Enovis — SWOT Analysis
Table 5. Enovis — Key Products and Platforms 2025
Table 6. Enovis — M&A Activity 2020-2025
Table 7. Enovis — Key Management 2025
Table 8. Enovis — Strategic Priorities 2025-2030
